• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Prothena - Articles and news items

parkinsons-disease

Prothena’s Phase 1b Parkinson’s disease study showed robust antibody CNS penetration

Industry news / 11 November 2016 / Niamh Louise Marriott, Digital Content Producer

Prothena’s Phase 1b multiple ascending dose study of PRX002 trial found an acceptable safety and tolerability profile in patients with Parkinson’s disease…

Amyloidosis - Printed Diagnosis with Mint Green Pills, Injections and Syringe

Prothena’s 2016 2nd quarter results support advancement of multiple clinical development programs

Industry news / 3 August 2016 / Prothena Corporation plc

Prothena Corporation plc has reported financial results for the second quarter and first six months of 2016. In addition, the Company provided an update on its R&D programs and 2016 financial guidance…

Prothena initiates NEOD001 global Phase 3 registrational trial

Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study

Industry news / 3 December 2014 / Prothena

Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study of NEOD001 in Patients With AL Amyloidosis…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +